SCHEMBL6659927

SCHEMBL6659927

CCOc1ccc(-c2ccc3c(ccn3-c3cccnc3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.56
CYP11B1 P15538 5/20 0.56
CYP19A1 P11511 3/20 0.56
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP17A1 P05093 2/20 0.41
GRM2 Q14416 1/20 0.41
NR3C1 P04150 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6660192 0.91 CYP11B1 (0.57) CYP11B2CYP11B1CYP19A1TP53SMN1; SMN2
SCHEMBL6840530 0.91 CYP11B2 (0.56) CYP11B2CYP11B1CYP19A1TP53SMN1; SMN2
SCHEMBL6656508 0.86 CYP11B2 (0.53) CYP11B2CYP11B1CYP19A1SMN1; SMN2NPC1
SCHEMBL6661401 0.84 CYP11B1 (0.49) CYP11B2CYP11B1CYP19A1SMN1; SMN2NPC1
SCHEMBL6663687 0.82 CYP11B2 (0.49) CYP11B2CYP11B1CYP19A1TP53SMN1; SMN2
SCHEMBL6846113 0.82 CYP11B2 (0.48) CYP11B2CYP11B1CYP19A1CYP3A4CYP17A1
SCHEMBL6655119 0.82 CYP11B2 (0.51) CYP11B2CYP11B1CYP19A1CYP3A4CYP17A1
SCHEMBL6846125 0.81 CYP11B2 (0.59) CYP11B2CYP11B1CYP19A1CYP3A4ALDH1A1
SCHEMBL6682744 0.80 CYP11B2 (0.50) CYP11B2CYP11B1CYP19A1CYP3A4CYP17A1
SCHEMBL22515748 0.80 CYP11B2 (0.49) CYP11B2CYP11B1CYP19A1CYP3A4CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432698-A2 SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027094-A2 SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed